CD4 and Parkinson disease: It has been shown that the transfer of CD4 + CD25 + Tregs to MPTP model mice with PD results in dose-dependent neuroprotective effects accompanied by inhibition of microglial activation, resulting in increased survival of dopaminergic neurons in the substantia nigra [99].